Abstract
Background A 68-year-old man diagnosed with primary plasma-cell leukemia was given thalidomide maintenance treatment for his disease. He had previously failed induction therapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone, but achieved complete remission after melphalan therapy. Multiple syncopal episodes started to occur during thalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.
Investigations Blood tests, peripheral blood smear, bone-marrow biopsy and aspirate, Holter electrocardiogram.
Diagnosis Sustained ventricular tachycardia possibly owing to thalidomide treatment.
Management Thalidomide withdrawal, dexamethasone maintenance therapy, monthly oral courses of combined melphalan and prednisone, salvage therapy with bortezomib.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121: 749–757
Kyle RA et al. (1974) Plasma cell leukemia: report on 17 cases. Arch Intern Med 133: 813–818
Garcia-Sanz R et al. (1999) Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 93: 1032–1037
Hayman SR and Fonseca R (2001) Plasma cell leukemia. Curr Treat Options Oncol 2: 205–216
Saccaro S et al. (2005) Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol 78: 288–294
Myeloma Trialists' Collaborative Group (2001) Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4,012 patients. Br J Haematol 113: 1020–1034
Thalidomide prescribing information (2006) (Celgene, Summit, NJ, USA)
Fahdi IE et al. (2004) Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol 93: 1052–1055
Johnston RE and Abdalla SH (2002) Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia. Leuk Lymphoma 43: 351–354
Petrucci MT et al. (2007) Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center. Leuk Lymphoma 48: 180–182
Wohrer S et al. (2004) Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone—a case report. Hematol J 5: 361–363
Attal M et al. (2006) Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood 108: 3289–3294
Musto P et al. (2007) Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer 109: 2285–2290
Acknowledgements
SB and EM contributed equally to this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ballanti, S., Mastrodicasa, E., Bolli, N. et al. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia. Nat Rev Clin Oncol 4, 722–725 (2007). https://doi.org/10.1038/ncponc1008
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ncponc1008
This article is cited by
-
Primary Plasma Cell Leukemia: Identity Card 2016
Current Treatment Options in Oncology (2016)
-
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Leukemia (2013)
